Ciaran Murray is the Chief Executive Officer of ICON. He joined ICON as Chief Financial Officer in 2005, serving in that capacity until his appointment as Chief Executive.  Prior to joining ICON, he held a number of senior financial positions in global organisations including Kraft Foods. Novell Inc. Northern Foods and Codec Systems.

He graduated with a Bachelor of Commerce degree from the University College Dublin and qualified as a Chartered Accountant with PwC
 

Brendan served as acting Chief Financial Officer since October 2011.  He was appointed Chief Financial Officer in February 2012 prior to this he served as ICON’s Senior Vice President of Corporate Finance and he has been a senior member of the ICON finance team since January 2006. 

Prior to joining ICON, Brendan held a senior corporate finance position in CRH plc, a major international building materials group. Brendan qualified as a Chartered Accountant with PricewaterhouseCoopers and obtained a Bachelor’s degree in Accounting and Finance from Dublin City University.
 

Eimear has served as the Executive Vice President Strategic Human Resource since April 2007, having previously held the position of Vice President Human Resources for ICON Clinical Research Europe and Rest of World since joining the company in November 1999.

Prior to joining ICON Ms. Kenny was HR Manager for GE Global Consumer Finance Ireland. Ms. Kenny holds a degree in both business studies Portobello college, Dublin & human resource management from the national college of Ireland. She is also a member of the Chartered Institute of Personnel and Development .

Simon Holmes serves as Executive Vice President Investor Relations and Corporate Development. In this role, Simon has responsibility for ICON's strategy development, merger and acquisition activity and also leads ICON's engagement with investors.

Mr. Holmes joined ICON in 2005 and prior to his current role, he served as ICON's Executive Vice President Group Marketing and Market Development. Mr. Holmes has held senior positions within Microsoft, LogicaCMG and Cable and Wireless.

A graduate of the University of East Anglia and Cambridge University Mr. Holmes holds an MBA from the UCD Smurfit Business School.

Michael McGrath is Executive Vice president of Group Information Technology for ICON PLC. He joined ICON in December 2002 having previously held a number of senior IT positions in the Financial Service Industry with GE Capital and Woodchester Bank Ltd. Prior to this he worked as an IT Consultant and also as a Software Engineer.

He has over 15 years experience in IT Industry across many areas including Pharmaceuticals, Financial Services and Utilities. He holds an MSc in Information Technology Management and a Degree in Electronic

Diarmaid Cunningham is ICON's General Counsel.  Diarmaid joined ICON as General Counsel in November 2009 having spent 10 years with A&L Goodbody which is one of Ireland's premier corporate law firms.  Diarmaid was appointed Company Secretary in October 2011.
 
Diarmaid graduated with a Bachelor of Business and Legal Studies from University College Dublin in 1997 and qualified as a Solicitor with A&L Goodbody in 2001.

In his role as Executive VP of Quality and Compliance, Dr. Neil McCullough will provide strategic direction for quality management & quality assurance across all lines of business, ensuring full compliance with global regulations guiding the biopharmaceutical industry.

Neil brings to ICON over 22 years of leading quality functions for global pharmaceutical and clinical research organisations. Prior to ICON, Neil led the global quality and compliance division of PPD, before which he spent nine years at Pfizer Inc. as a member of the Pfizer Global Medical Quality Assurance Leadership team. Prior to Pfizer, Neil served as a quality consultant to GlaxoSmithKline's division of manufacturing.

Neil earned his doctorate in chemistry from the University of Kent at Canterbury in the UK and his masters in pharmaceutical medicine from Hibernia College, Dublin, in partnership with Harvard University and the Royal College of Physicians, Ireland.

Robert Howie is Chief Marketing Officer of ICON.  Prior to joining the company, he co-founded two management consultancies, Palladium Group and Balanced Scorecard Collaborative, and held a number of management positions at DMR Group, Yankee Group, Exxon Office Systems, and Houghton Mifflin Company. 
 
He holds undergraduate and graduate degrees with distinction from Boston College. 
 

Dr. Steve Cutler was appointed Group President, Clinical Research Services in November 2011.

Steve has over 23 years’ experience within the pharmaceutical and CRO industry and joined ICON from Kendle where he held the position of Chief Executive Officer, having previously served as Kendle’s Chief Operating Officer. Prior to Kendle, Steve spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Steve held positions with Sandoz (now Novartis) in Australia and Europe. He holds a B.Sc. and a PhD from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).

Dr. Mario Rocci joined ICON as the former CEO of Prevalere Life Sciences, Inc. (a wholly owned subsidiary of ICON plc) in 2008. He served as Executive Vice President of Global Bioanalytical Sciences, overseeing ICON’s expanding Bioanalytical Sciences group, until his current appointment as President, ICON Development Solutions.

Mario's 29 years of industry experience includes positions such as Head of the Laboratory of Investigative Medicine and Research Associate Professor of Medicine at Thomas Jefferson University, where he was part of a team of Clinical Pharmacologists conducting Phase I-IV clinical studies on drugs undergoing development. Dr. Rocci was also a Clinical Associate Professor of Pharmacy Practice at the Philadelphia College of Pharmacy and Science.

Actively involved in the industry, Dr. Rocci served as the 2004 President of the American Association of Pharmaceutical Scientists (AAPS), a professional society of over 12,000 members, having previously been elected to a three year term on the AAPS Board of Directors. He also serves on the Board of Directors for the International Pharmaceutical Federation (FIP) and is Chairman of the Board of the Product Quality Research Institute (PQRI). He has authored over 125 scientific publications and has extensive experience in the pharmaceutical sciences and the regulatory requirements of the FDA.

Dr. Rocci earned a Ph.D. in Pharmaceutics and a B.S. in Pharmacy from the State University of New York at Buffalo.
 

Colin Stanley is President of DOCS. He has over 14 years of experience working in the CRO industry. He joined ICON as a Project Manager in 2001 and has since held a range of positions of increasing responsibility. Since January 2011 Colin held the position of Chief Operating Offer for DOCS returning from Asia where he was Vice President of Clinical Operations, Asia Pacific with responsibility for all projects and staff in the region. Previous to this he was Director of Clinical Operations based in the US and in 2005 he led IMPROVE, a global Initiative focused on process improvement across all aspects of ICON’s business. He has also held various positions in Data Management including Head of Data Management, Europe. Colin started his career in Data Management at Quintiles.

Colin holds a Bachelor’s Degree in Biotechnology from Dublin City University.